📰 Ip Group News
Page 55 - Ip Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ip Group. Real-time updates on events, politics, business and more.
October 14, 2021
STORM to deliver small molecule ADAR1 clinical candidate compounds discovered using its proprietary RNA modifying enzyme drug discovery platform ALAMEDA, Calif. and CAMBRIDGE, England,
October 14, 2021
STORM to deliver small molecule ADAR1 clinical candidate compounds discovered using its proprietary RNA modifying enzyme drug discovery platform - Exelixis, Inc. (Nasdaq: EXEL) and STORM Therapeutics
October 14, 2021
Investegate announcements from IP Group PLC, Transaction in Own Shares
October 13, 2021
Investegate announcements from IP Group PLC, Director Declaration
October 13, 2021
Investegate announcements from IP Group PLC, Transaction in Own Shares
October 12, 2021
Collaborative team to progress novel USP30 DUB inhibitors to develop potential therapies for Parkinson's disease Mission Therapeutics ("Mission"), a drug discovery and development company focused
October 12, 2021
IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares | Financial News
October 12, 2021
Questor share tip: genetic sequencer’s recent float gave the fund’s net asset value a boost, but it offers other promising businesses too
October 12, 2021
Investegate announcements from IP Group PLC, Transaction in Own Shares
October 11, 2021
A record £3bn ($4bn) has been raised by the UK biotech and life science sector in the first three quarters of 2021.